Tectonic Therapeutic | AVRO - الأصول





الأصول تغيير تاريخ
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Celltrion KRW 759.44B 20.32T 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
MacroGenics USD 217.87M 38.97M 2026-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pfizer USD 207.62B 542M 2026-03
Pharma Mar EUR 385.26M 9.82M 2026-03
Qiagen NV USD 6.3B 257.54M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 128.02B 1.22B 2026-03
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Takeda JPY 15.45T 44.34B 2026-03
Tilray USD 2.1B 15.95M 2025-09
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03